Evanesco Therapeutics, a BridgeBio affiliate, is developing a next-generation monoclonal antibody depleter for transthyretin amyloid cardiomyopathy (ATTR-CM). Its approach is designed to clear amyloid already deposited in the heart. Following development candidate nomination, the program is preparing for IND submission, with first-in-human studies to follow. The role is part of a small, fast-moving team with startup autonomy inside an established company, offering direct involvement from preclinical data through clinical strategy. The Business Development & Operations leader will own and shape the scientific, operational, and external-facing aspects of value-driving subsidiaries, including their business and scientific plans, strategy, and budgets. The role applies an understanding of molecular biology to interpret and question scientific strategy, while managing competitive intelligence, financial modeling, and academic and industry relationships. The successful candidate will be a detailed, rational problem-solver who thinks independently and inspires excellence across the team.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree